INTRODUCTION

29
A growing number of epidemiologic studies have 30 shown that higher levels of caffeine or coffee intake GCSF levels and cognitive performance in long-term 342 treated mice; the full spectrum of measures will be 343 presented in a separate study focusing on behavior.
344
As such, the "three trial recall" measure currently pre- (Fig. 3a, d ). As well, there were no pre-treatment ver- . In 6-8 month old non-transgenic (NT) mice, acute treatment with coffee (concentrated or un-concentrated) substantially increased plasma levels of GCSF, IL-10, and IL-6 at 3 h post-treatment, as indexed by the difference between post-and pre-treatment levels. Caffeine solution, concentrated decaffeinated coffee, or saline treatment had no such effect on any of these cytokines. ***p < 0.02 or higher level of significance vs all three non-asterisk groups; **p < 0.01 or higher level of significance versus all other groups; *p < 0.05 or higher level of significance versus all three non-asterisk group.
mice were greatly and similarly increased at 3 h follow- Long-term treatment study 515 In this study, 10 month old A␤PPsw (Tg) mice
516
were given twice-weekly gavage treatment with either 517 Caffeine (ng/ml) Theophylline (ng/ml) Fig. 5 . In non-transgenic (NT) mice aged 6-8 months, acute treatment resulted in much higher plasma caffeine levels in mice given either caffeine solution or concentrated coffee, compared to the other three treatment groups. **p < 0.000001 versus caffeine levels in saline, concentrated decaf, and un-concentrated coffee groups; † p < 0.05 or higher level of significance versus Concentrated Decaf group. Plasma theophylline levels in the same post-treatment blood samples were highest with caffeine treatment, followed by concentrated coffee treatment; both of these groups had theophylline levels significantly higher than the other three treatment groups. ***p < 0.00005 versus all other groups; *p < 0.002 or higher level of significance versus all other groups.
saline, decaffeinated coffee (concentrated), or caf- 6 . a, c) A␤PPsw (Tg) mice were cognitively evaluated at three months into bi-weekly gavage treatment with decaffeinated coffee, coffee, or saline control. In the 3-Trial Recall measure of the cognitive interference task, both Tg controls and Tg mice being treated with decaffeinated coffee (Tg+Decaf) were impaired in both errors (a) and escape latency (c) compared to NT controls. By contrast, Tg mice being given chronic coffee treatment showed performance levels in both measures that were no different from NT controls. Performance of all Tg groups for both measures was indexed and statistically evaluated as percent change from the performance of NT controls. *p < 0.05 or higher level of significance versus NT controls. b, d) Irrespective of whether decaf or coffee treatment was given to Tg mice, their errors and latency in 3-Trial Recall were both inversely correlated with plasma GCSF levels. Better cognitive performance was present in Tg mice with higher plasma GCSF levels.
cognitive interference task of working memory over no different from NT controls (Fig. 6a, c) . Plasma
531
GCSF levels from individual Tg mice irrespective of 532 coffee-or decaffeinated-coffee treatment revealed an 533 inverse correlation with both errors and latency in 3-
534
Trial Recall (Fig. 6b, d ). Tg mice with higher plasma 
582
In the present study, acute administration of coffee
583
(but not caffeine or decaffeinated coffee), induced a 584 large increase in plasma GCSF levels 3 h thereafter.
585
This coffee-induced increase in GCSF was indepen-586 dent of genotype in that it was seen not only in 
